Scarica l'app Stockscreener
0.248
3.80%
-0.0098
Dopo l'orario di chiusura:
.25
0.002
+0.81%
Precedente Chiudi:
$0.2578
Aprire:
$0.2455
Volume 24 ore:
267.32K
Relative Volume:
0.83
Capitalizzazione di mercato:
$4.29M
Reddito:
$7.78M
Utile/perdita netta:
$-3.11M
Rapporto P/E:
-0.5167
EPS:
-0.48
Flusso di cassa netto:
$-72,500
1 W Prestazione:
-2.90%
1M Prestazione:
-0.36%
6M Prestazione:
-22.09%
1 anno Prestazione:
-47.84%
Intervallo 1D:
$0.2411
$0.2597
Intervallo di 1 settimana:
$0.2403
$0.2637
Portata 52W:
$0.17
$1.1575
China Pharma Holdings Inc. Stock (CPHI) Company Profile
Nome
China Pharma Holdings Inc.
Settore
Telefono
86 898 6681 1730
Indirizzo
No. 17, Jinpan Road, Second Floor, Haikou
China Pharma Holdings Inc. Stock (CPHI) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2010-01-08 | Iniziato | Rodman & Renshaw | Mkt Outperform |
China Pharma Holdings Inc. Borsa (CPHI) Ultime notizie
Stock Market Movers Today • Top Gainers & Losers - Benzinga
Layoff Tracker: Compass Pathways to Lay Off 30% of Employees - BioSpace
AstraZeneca says its China operations president under investigation - Reuters
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Shares Bought by China Universal Asset Management Co. Ltd. - MarketBeat
Pre-market Movers: EVOK, HCTI, GLUE, MNPR... - RTTNews
RRJ Buys $150 Million Luye Bonds, First China Deal Since 2019 - BNN Bloomberg
Insiders of China Medical System Holdings Limited (HKG:867) must be disappointed as stock fell 4.7% after recent purchases - Simply Wall St
AI Redefines the Pharmaceuticals Wholesale and Distribution Market, Projected to Grow by USD 896.5 Billion from 2024-2028, Boosting Global Sales - The Malaysian Reserve
China Pharma (NYSE:CPHI) Research Coverage Started at StockNews.com - Defense World
China Constipation Treatment Drug Industry Growth Factors, Applications, and Forecast by (2024-2034) - IndiaPolitics.com
China Pharma Holdings Inc. (CPHI) is a good investment, but the stock may be undervalued - US Post News
The Psychology of China Pharma Holdings Inc. Inc. (CPHI) Price Performance: Understanding Market Sentiment - The InvestChronicle
CPHI’s 52-Week Rollercoaster: From $0.17 to $1.21 – What’s Next for Investors? - The InvestChronicle
Analytical Overview: China Pharma Holdings Inc. (CPHI)’s Ratios Tell a Financial Story - The Dwinnex
China's WuXi explores sale of pharma operations as US restrictions loom, FT reports - Yahoo Finance
Check out these key findings about China Pharma Holdings Inc. (CPHI) - SETE News
PDD Holdings: China Stimulus Adds Rocket Fuel, Reiterate Buy - Seeking Alpha
LEO Pharma announces Enstilar NDA submission for plaque psoriasis in China - Yahoo Finance
Here's Why Yum China Holdings (YUMC) is a Strong Growth Stock - Yahoo Finance
China Pharma (NYSE:CPHI) Coverage Initiated by Analysts at StockNews.com - Defense World
CPHI’s Market Seesaw: Yearly Gains & Recent Declines – What to Expect? - The InvestChronicle
LEO Pharma Submits New Drug Application for Enstilar® for Adults with Plaque Psoriasis in China - Yahoo Finance
Haleon Increases Stake in China JV to 88% for GBP500 Million - Marketscreener.com
China's Bold Stimulus Measures: What It Means for Markets - Saxo Bank
Tonix Pharmaceuticals Announces Data Presentations on TNX-102 SL for Fibromyalgia at the 11th Global Conference on Pharmaceutics and Novel Drug Delivery Systems (PDDS 2024) - Yahoo Finance
CSPC Pharma taps R&D superstar in quest for new breakout drugs - Bamboo Works
StockNews.com Begins Coverage on China Pharma (NYSE:CPHI) - Defense World
Yum China Holdings, Inc. (YUMC): Analysts Are Bullish On This Undervalued Cyclical Stock Now - Yahoo Finance
Investing in China Pharma Holdings Inc. (CPHI) might be an excellent idea, but the stock is currently overvalued/undervalued – US Post News - US Post News
China Pharma Holdings Inc.: Weathering Stock Market Storms with 4.04M Market Cap - The InvestChronicle
China Pharma (NYSE:CPHI) Coverage Initiated at StockNews.com - Defense World
Big pharma eyes China ‘at forefront of GLP-1 revolution’ - BioWorld Online
US House Passes Bill to Blacklist Some China Biotech Firms - Yahoo Finance
Summit’s checkpoint inhibitor trumps Keytruda in lung cancer trial - Clinical Trials Arena
Plasma Fractionation Market Size to Expand Lucratively by 2031 - WhaTech
Stocks to Watch, Sep 6: Glenmark Pharma, Godfrey, Max Fin Svcs, Pidilite - Business Standard
AstraZeneca In Trouble For Employee Detentions in China Over Illegal Activities - Yahoo Finance
China Pharma (NYSE:CPHI) Earns Hold Rating from Analysts at StockNews.com - Defense World
China Medical System Holdings First Half 2024 Earnings: EPS: CN¥0.37 (vs CN¥0.78 in 1H 2023) - Simply Wall St
Jacobio Pharma grants Allist rights to two assets in China - Yahoo Finance
Corbus Pharmaceuticals Holdings, Inc. (CRBP): One of Oppenheimer's Top Stock Picks For the Next 12 Months - MSN
HSI Down 182 pts; HSTI Down 55 pts; MEITUAN Down over 3%; HANSOH PHARMA, CKI HOLDINGS, CLP HOLDINGS, CHINA TAIPING, ASCENTAGE Hit New Highs - AASTOCKS.com
HSI Closes Midday at 17,700, Down 173 pts; HSTI Closes Midday at 3,437, Down 63 pts; NONGFU SPRING Down over 11%; HANSOH PHARMA, CKI HOLDINGS, CLP HOLDINGS, CKH HOLDINGS, CHINA TAIPING Hit New Highs - AASTOCKS.com
Corbus Pharmaceuticals Holdings, Inc. (CRBP): One of Oppenheimer’s Top Stock Picks For the Next 12 Months - Insider Monkey
China Nt Pharma Group Company Limited Reports Earnings Results for the Half Year Ended June 30, 2020 - Marketscreener.com
Belgium's UCB to sell China neurology, allergy business for $680 mln - Reuters
Mayne Pharma Group Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance
5 Biggest Pharmaceutical ETFs in 2024 - Investing News Network
Vanguard Group Inc. Increases Stake in iShares MSCI China ETF (NASDAQ:MCHI) - Defense World
TopBrand 2024 Top 500 Global Brands List released, with Apple as defending champion - The Manila Times
China Pharma Holdings, Inc. expects to launch its Dry Eye Disease Therapeutic Device in the first quarter of 2025 - The Manila Times
China Pharma Holdings Inc. Azioni (CPHI) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.88%
0.42%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Capitalizzazione:
|
Volume (24 ore):